SynthesisThe European journal of health economics : HEPAC : health economics in prevention and care2019

Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review.

Jessica Y Matuoka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.